News

Abiomed announced two approvals from the U.S. Food and Drug Administration (FDA) related to clinical research of Impella heart pumps in acute myocardial infarction (AMI) cardiogenic shock patients.

Impella will be featured in presentations on topics that include a new analysis of data from the STEMI-DTU pilot randomized controlled trial and new data on cardiogenic shock and myocarditis outcomes from the J-PVAD registry in Japan.

The Manta Device is the first commercially available biomechanical vascular closure device designed specifically for large bore femoral arterial access site closure.

Obese women who use oral contraceptives containing oestrogen and progestin have a 24-fold increased risk of venous thromboembolism (VTE) compared with non-obese women not using the drugs.

Edwards Lifesciences Corporation (NYSE: EW), today announced the company's PASCAL Precision transcatheter valve repair system for transcatheter edge-to-edge repair (TEER) has received FDA approval for the treatment of patients with...

September 15, 2022 — The conventional wisdom is that medical and dental care are related, but less is known about how dental care relates to health outcomes after acute incidents like heart attacks. To that end, University of Michigan...

The SavvyWire is the first and only Sensor-Guided TAVR solution, designed to support TAVR efficiency and lifetime patient management.

The Cardiovascular Research Foundation (CRF) will honor Valentin Fuster, MD, PhD, Director of Mount Sinai Heart and Physician-in-Chief of The Mount Sinai Hospital, with the Transcatheter Cardiovascular Therapeutics (TCT) 2022 Career...

Annuloplasty device demonstrates advantage of 2-stage approach using a device specifically designed for the tricuspid heart valve.

WINSTON-SALEM, N.C. – Sept. 14, 2022 – Could taking a daily multivitamin help maintain cognitive health with aging and possibly prevent cognitive decline? According to new research from Wake Forest University School of Medicine,...